Table: Cosmos Pharmaceutical -Q1 group results

Cosmos Pharmaceutical

11/10/2023 07:00

Oct 11 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2023        Aug 31, 2022     May 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            241.65              206.12           916.00    
                 (+17.2 pct)         (+8.8 pct)       (+10.7 pct) 
  Operating          8.99                8.90            30.20    
                 (+1.0 pct)          (+4.0 pct)       (+0.2 pct)  
  Recurring          9.70                9.63            33.20    
                 (+0.8 pct)          (+3.5 pct)       (+0.3 pct)  
  Net                6.51                6.48            23.80    
                 (+0.4 pct)          (+3.8 pct)       (+0.0 pct)  
  EPS            164.35 yen          163.68 yen       601.03 yen  
  Ann Div                            100.00 yen       120.00 yen  
  -Q2 div                             42.50 yen        60.00 yen  
  -Q4 div                             57.50 yen        60.00 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T